UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform
Computational advancements enable earlier and more widespread use of antibody-antigen structural insights across drug discovery process These advancements have the potential to transform antibody discovery methods, broadening therapeutic applications and accelerating the development of innovative molecules CAMBRIDGE, Mass. and BRUSSELS, Jan. 9, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical...
Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency
FRANKFURT, Germany, Jan. 9, 2025 /PRNewswire/ -- Anbio Biotechnology ("Anbio"), a global leader in diagnostics innovation, announces the launch of its Dry Chemiluminescence Immunoassay (CLIA) Solution ADL-1000, a transformative technology designed to deliver rapid, reliable, and cost-effective diagnostic results. Tailored for diverse clinical settings, this solution addresses the growing demand for streamlined workflows and high-performance testing. ...
FlexiAchiever Savings Plan Flexible financial solution integrating wealth accumulation, liquidity and legacy planning to save up for a world of possibilities
Enjoy a premium refund of up to 13% upon successful application HONG KONG, Jan. 9, 2025 /PRNewswire/ -- AIA Hong Kong & Macau announces the launch of the FlexiAchiever Savings Plan that integrates long-term wealth accumulation, liquidity, and legacy planning. The Plan is designed to empower customers to address their future needs through flexible financial management, enabling them to reach...
RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months
BEIJING, Jan. 9, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically "undruggable" protein, in just two months. This innovative AI-driven approach combines advanced algorithms, physics simulations, and high-throughput experimentation to rapidly develop potential drug candidates for challenging targets. The platform's success with β-catenin, a key player...
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise INCHEON, South Korea, Jan. 9, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to extend collaboration with LigaChem Biosciences (KOSDAQ: 141080) to provide antibody-drug...
Holistic care for senior citizen parents of NRIs: Policybazaar and insurer partners join hands for elderly support services
GURUGRAM, India, Jan. 9, 2025 /PRNewswire/ -- Policybazaar, in collaboration with its insurer partners, has lifted the caregiving worry off the shoulders of its NRI customers by introducing a range of comprehensive services as part of the NRI Care Program. The program includes benefits such as dedicated NRI concierge services including hospitalization and...
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu
CAMBRIDGE, England and SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated by its "First in Human" Coronavirus vaccine trial, to announce its new portfolio of pre-pandemic Bird-Flu, supra-Seasonal and Universal-type Influenza vaccines, alongside the unveiling of its new advisory board. The...
This Tech at CES 2025 Might Make Your New Year’s Resolution a Reality
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- Could this be the year your fitness goals finally stick? Speediance-CES-Halls D #55532 at The Venetian Expo Speediance, the emerging leader in smart fitness, is bringing groundbreaking technology to CES 2025, promising to revolutionize the way we approach health and wellness. At the heart of its...
Wondfo Brings Fast and Reliable Rapid Testing Solution Brands to CES 2025
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- Wondfo USA Co., Ltd. ("Wondfo" or "Company"), a leading brand in medical diagnostic testing solutions and technologies, showcased its commitment to the North American market by presenting a diverse range of products at CES 2025. The Wondfo USA WELLlife and Wondfo USA HORMONElife brands offer reliable testing in several areas to keep...
Dx&Vx, From mRNA Vaccines to Nanoparticle Vaccines era of Next-Generation Vaccines
Introduction of a Universal Coronavirus Vaccine: A robust cross-immunity effect to combat virus mutations. SEOUL, South Korea, Jan. 8, 2025 /PRNewswire/ -- The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in infectious disease response, highlighting the need for swift action. Despite...
